Acting Manhattan U.S. Attorney announces $678 million settlement of fraud lawsuit against Novartis Pharmaceuticals Corporation for operating sham speaker programs through which it paid over $100 million to doctors to unlawfully induce them to prescribe Novartis cardiovascular and diabetes drugs reimbursed by federal healthcare programs. Click here for full story.